Tirzepatide (30 mg) is a synthetic lipidated peptide composed of 39 amino acids with a C20 fatty diacid moiety, supplied for laboratory research on metabolic regulation. The tirzepatide peptide has been studied for dual agonist activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor targets, supporting experimental work in metabolic biology.